Table 2 |
|||
|
Significant GO processes |
|||
|
GO term |
Description |
Permutation p-value (weighted approach) |
Permutation p-value (unweighted approach) |
|
|
|||
|
GO:0000186† |
Activation of MAP kinase activity, especially during sporulation |
<1.0 × 10–6 |
4.0 × 10–5 |
|
GO:0001569†* |
Branching involved in blood vessel morphogenesis |
<1.0 × 10–6 |
<1.0 × 10–6 |
|
GO:0001666†* |
Response to lowered oxygen tension |
<1.0 × 10–6 |
1.0 × 10–6 |
|
GO:0001938†* |
Up-regulation of endothelial cell proliferation |
<1.0 × 10–6 |
<1.0 × 10–6 |
|
GO:0002040†* |
Sprouting angiogenesis |
<1.0 × 10–6 |
<1.0 × 10–6 |
|
GO:0006355†* |
Regulation of cellular transcription, DNA-dependent |
<1.0 × 10–6 |
<1.0 × 10–6 |
|
GO:0006916* |
Anti-apoptosis |
7.5 × 10–5 |
1.0 × 10–6 |
|
GO:0006940†* |
Any process that modulates the frequency, rate, or extent of smooth muscle contraction |
<1.0 × 10–6 |
<1.0 × 10–6 |
|
GO:0006952 † |
Defense/immunity protein activity |
8.0 × 10–6 |
1.9 × 10–5 |
|
GO:0007169†* |
Transmembrane receptor protein tyrosine kinase signaling pathway |
<1.0 × 10–6 |
<1.0 × 10–6 |
|
GO:0008152† |
Metabolic process |
3.0 × 10–6 |
2.2 × 10–5 |
|
GO:0010595†* |
Up-regulation of endothelial cell migration |
<1.0 × 10–6 |
7.0 × 10–6 |
|
GO:0030097† |
Blood cell formation |
<1.0 × 10–6 |
(a) |
|
*GO:0030522†* |
Intracellular receptor-mediated signaling pathway |
<1.0 × 10–6 |
<1.0 × 10–6 |
|
GO:0030949†* |
Up-regulation of vascular endothelial growth factor (VEGF) receptor signaling pathway |
<1.0 × 10–6 |
<1.0 × 10–6 |
|
GO:0043129†* |
Surfactant homeostasis |
<1.0 × 10–6 |
1.1 × 10–5 |
|
GO:0045446† |
Endothelial cell differentiation |
<1.0 × 10–6 |
(a) |
|
GO:0045745* |
Positive regulation of G-protein coupled receptor protein signaling pathway |
6.425 × 10–2 |
1.2 × 10–5 |
|
GO:0048286†* |
Lung alveolus development |
<1.0 × 10–6 |
5.0 × 10–6 |
|
GO:0048661†* |
Up-regulation of smooth muscle cell proliferation |
<1.0 × 10–6 |
<1.0 × 10–6 |
|
GO:0050927† |
Up-regulation of positive chemotaxis |
<1.0 × 10–6 |
(a) |
|
GO:0051894† |
Up-regulation of focal adhesion formation |
<1.0 × 10–6 |
(a) |
|
GO:0055074† |
Regulation of calcium ion concentration |
<1.0 × 10–6 |
(a) |
|
|
|||
|
† Pathways (processes) that are significant using the weighted approach. * Pathways (processes) that are significant using the unweighted approach. a Once 100 permuted data sets were found to have a larger Wald statistic for a given process than that observed in the original (unpermuted) data set, that process was deemed nonsignificant and further permutations were not performed. |
|||
|
Xing et al. BMC Proceedings 2011 5(Suppl 9):S6 doi:10.1186/1753-6561-5-S9-S6 |
|||